252 related articles for article (PubMed ID: 24389287)
1. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.
Wolter JK; Wolter NE; Blanch A; Partridge T; Cheng L; Morgenstern DA; Podkowa M; Kaplan DR; Irwin MS
Oncotarget; 2014 Jan; 5(1):161-72. PubMed ID: 24389287
[TBL] [Abstract][Full Text] [Related]
2. HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma.
Shi Y; Takenobu H; Kurata K; Yamaguchi Y; Yanagisawa R; Ohira M; Koike K; Nakagawara A; Jiang LL; Kamijo T
Eur J Cancer; 2010 Aug; 46(12):2324-34. PubMed ID: 20591651
[TBL] [Abstract][Full Text] [Related]
3. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma.
Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G
Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426
[TBL] [Abstract][Full Text] [Related]
4. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effect of sulfasalazine in neuroblastoma.
Mooney MR; Geerts D; Kort EJ; Bachmann AS
Biochem Pharmacol; 2019 Apr; 162():237-249. PubMed ID: 30639262
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
7. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
[TBL] [Abstract][Full Text] [Related]
8. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effect of propranolol on the growth of the neuroblastoma xenografts in nude mice.
Xu T; Xiao X; Zheng S; Zheng J; Zhu H; Ji Y; Yang S
J Pediatr Surg; 2013 Dec; 48(12):2460-5. PubMed ID: 24314187
[TBL] [Abstract][Full Text] [Related]
10. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo.
Geng X; Xie L; Xing H
Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
[TBL] [Abstract][Full Text] [Related]
12. Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.
Ejeskär K; Sjöberg RM; Kogner P; Martinsson T
Int J Mol Med; 1999 Jun; 3(6):585-9. PubMed ID: 10341287
[TBL] [Abstract][Full Text] [Related]
13. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
Tanos R; Karmali D; Nalluri S; Goldsmith KC
BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
[TBL] [Abstract][Full Text] [Related]
14. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways.
Cheng J; Fan YH; Xu X; Zhang H; Dou J; Tang Y; Zhong X; Rojas Y; Yu Y; Zhao Y; Vasudevan SA; Zhang H; Nuchtern JG; Kim ES; Chen X; Lu F; Yang J
Cell Death Dis; 2014 Feb; 5(2):e1079. PubMed ID: 24556694
[TBL] [Abstract][Full Text] [Related]
15. Nuclear receptor NR5A2 negatively regulates cell proliferation and tumor growth in nervous system malignancies.
Gkikas D; Stellas D; Polissidis A; Manolakou T; Kokotou MG; Kokotos G; Politis PK
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34561301
[TBL] [Abstract][Full Text] [Related]
16. Propranolol sensitizes thyroid cancer cells to cytotoxic effect of vemurafenib.
Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
Oncol Rep; 2016 Sep; 36(3):1576-84. PubMed ID: 27432558
[TBL] [Abstract][Full Text] [Related]
17. Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis.
Chen Z; Wang L; Yao D; Yang T; Cao WM; Dou J; Pang JC; Guan S; Zhang H; Yu Y; Zhao Y; Wang Y; Xu X; Shi Y; Patel R; Zhang H; Vasudevan SA; Liu S; Yang J; Nuchtern JG
Sci Rep; 2016 Dec; 6():38011. PubMed ID: 27991505
[TBL] [Abstract][Full Text] [Related]
18. Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway.
Zhou C; Chen X; Zeng W; Peng C; Huang G; Li X; Ouyang Z; Luo Y; Xu X; Xu B; Wang W; He R; Zhang X; Zhang L; Liu J; Knepper TC; He Y; McLeod HL
Oncotarget; 2016 Oct; 7(42):68314-68327. PubMed ID: 27582542
[TBL] [Abstract][Full Text] [Related]
19. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
[TBL] [Abstract][Full Text] [Related]
20. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
